Rocket, Lab’s

Rocket Lab’s $57B Valuation Priced for Neutron Perfection as Record Backlog and Defense Wins Mount

11.05.2026 - 04:26:54 | boerse-global.de

Rocket Lab shares surged 34% to a record $105.47 after Q1 revenue beat estimates and a massive Neutron contract. Analysts raise targets to $120, but Neutron timeline risks remain.

Rocket Lab’s $57B Valuation Priced for Neutron Perfection as Record Backlog and Defense Wins Mount - Foto: über boerse-global.de
Rocket Lab’s $57B Valuation Priced for Neutron Perfection as Record Backlog and Defense Wins Mount - Foto: über boerse-global.de

Rocket Lab entered the new trading week with a market capitalization north of $57 billion, after a stunning 34% single-day surge propelled its shares to a record close of $105.47 on Friday. The rally — a near 400% gain over the past twelve months — reflects deep investor conviction that the company is on the cusp of a transformational era. Yet with the current price already discounting a smooth Neutron debut, any slippage in that timeline could trigger a sharp correction.

The catalyst for Friday’s explosion was a double dose of bullish news. First, Rocket Lab’s first-quarter revenue broke through the $200 million barrier for the first time, hitting a year-over-year increase of roughly 63% and handily beating analyst estimates. The space systems unit contributed the lion’s share at nearly $137 million. Second, the company disclosed a monumental contract — the largest single deal in its history — from an unnamed customer ordering five Neutron launches and three Electron missions scheduled between 2026 and 2029. That pushed the total order book to a record $2.2 billion, spanning more than 70 missions. In the first three months of 2026 alone, Rocket Lab signed 36 new launch contracts, exceeding the total for all of last year.

The narrative around the stock now revolves almost entirely around the Neutron rocket. The first orbital flight remains slated for the fourth quarter of 2026, and CEO Peter Beck confirmed significant design improvements to the first stage. To maximize the probability of a successful debut, the team will skip a landing attempt on the first flight, reserving a floating ocean platform for the second mission. A known issue with the first-stage main propellant tank has raised questions, but management has not indicated whether it threatens the schedule. The massive new contract adds credibility to the timeline, with management insisting it did not offer discounts to fill the backlog.

Should investors sell immediately? Or is it worth buying Rocket Lab USA?

Meanwhile, Rocket Lab is deepening its footprint in the defense sector. The company was selected alongside Raytheon for a Space Based Interceptor demonstration program under the U.S. Space Force. Separately, it secured a $30 million contract with Anduril for hypersonic missions under the HASTE variant, which now accounts for nearly a third of the total launch portfolio. These government ties provide a stable revenue stream that complements the growing commercial order book.

The financial runway looks equally robust. Rocket Lab holds more than $2 billion in cash and is set to close the acquisition of Motiv Space Systems in the near term. For the current quarter, management expects revenue between $225 million and $240 million — well above the consensus estimate of roughly $205 million. That guidance implies a further acceleration from the first quarter’s performance.

Analysts have responded with a flurry of target upgrades. TD Cowen raised its price objective to $120, while CFRA maintained a “Strong Buy” rating and lifted its target from $80 to $100 — still below the current market price. The median target across 23 Wall Street analysts stood at $88.88 before Friday’s move, suggesting that many strategists may now scramble to revise their numbers upward. Yet some market observers caution that the current valuation fully prices in a punctual Neutron debut in late 2026. Any delay — whether from the tank issue or launch-site readiness in Virginia — could puncture the euphoria quickly.

Margins remain negative, and the stock’s meteoric rise leaves little room for error. For now, Rocket Lab has the contracts, the cash, and the momentum to keep the faith alive. But the next few months will be critical: concrete updates on the Neutron hardware and launch infrastructure will either validate the sky-high multiples or expose them as unsustainable. The countdown to Q4 2026 has already begun, and the market is listening intently for each tick of the clock.

Ad

Rocket Lab USA Stock: New Analysis - 11 May

Fresh Rocket Lab USA information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated Rocket Lab USA analysis...

So schätzen die Börsenprofis Rocket Aktien ein!

<b>So schätzen die Börsenprofis Rocket Aktien ein!</b>
Seit 2005 liefert der Börsenbrief trading-notes verlässliche Anlage-Empfehlungen – dreimal pro Woche, direkt ins Postfach. 100% kostenlos. 100% Expertenwissen. Trage einfach deine E-Mail Adresse ein und verpasse ab heute keine Top-Chance mehr. Jetzt abonnieren.
Für. Immer. Kostenlos.
en | US7731221062 | ROCKET | boerse | 69302296 |